发明名称 |
SUSTAINED-RELEASE FORMULATIONS OF TOPIRAMATE |
摘要 |
Pharmaceutical compositions of topiramate for once-a-day oral administration are provided. The formulations comprise a sustained-release component and an optional immediate-release component, the compositions of which can be selectively adjusted, respectively, to release the active ingredient along a pre-determined release profile. Method of treating or preventing pathological disorders in mammalian subjects comprising the administration of the novel formulations disclosed herein is also provided. |
申请公布号 |
US2012321708(A1) |
申请公布日期 |
2012.12.20 |
申请号 |
US201213595103 |
申请日期 |
2012.08.27 |
申请人 |
LIANG LIKAN;WANG HUA;BHATT PADMANABH P.;VIEIRA MICHAEL L.;SUPERNUS PHARMACEUTICALS, INC. |
发明人 |
LIANG LIKAN;WANG HUA;BHATT PADMANABH P.;VIEIRA MICHAEL L. |
分类号 |
A61K31/35;A61K9/24;A61K9/50;A61K9/54;A61P3/10;A61P9/12;A61P17/02;A61P25/00;A61P25/02;A61P25/06;A61P25/08;A61P25/18;A61P25/22;A61P25/28;A61P25/30;A61P37/00 |
主分类号 |
A61K31/35 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|